Welltower Inc.

NYSE:WELL

REIT - Healthcare Facilities

Real Estate
$247.25 +0.21%

+$0.44 today

Market cap
$181.39B
Beta
0.78
P/E (TTM)
102.9
EPS (TTM)
$2.01
Dividend yield
1.43%
52W Low $148.97High $221.68

Volume 4.27M

Average 3.24M

WELL Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Welltower Inc.NYSE: WELL

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How WELL compares with its peers on the latest reported figures

  • WELL's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for WELL, versus a peer median of 0.0%.
WELL Competitors Peer median
Research & Development for WELL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELLWelltower Inc.LTM Sep 2026$0 ——0.0%
VTRVentas, Inc.LTM Jun 2026$0 ——0.0%
OHIOmega Healthcare Investors, Inc.LTM Jun 2026$0 ——0.0%
DOCHealthpeak Properties, Inc.LTM Sep 2026$0 ——0.0%
AHRAmerican Healthcare REIT, Inc.LTM Sep 2026$0 ——0.0%
CTRECareTrust REIT, Inc.LTM Sep 2026$0 ——0.0%
SBRASabra Health Care REIT, Inc.LTM Jun 2026$0 ——0.0%
NHINational Health Investors, Inc.LTM Sep 2026$0 ——0.0%
LTCLTC Properties, Inc.LTM Sep 2026$0 ——0.0%
MPTMedical Properties Trust, Inc.LTM Jun 2026$0 ——0.0%
NHPBPNational Healthcare Properties, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding WELL) $0——0.0%

Competitors are the stored peer set for WELL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.71B5.78B6.48B7.85B10.67B
Cost of Revenue2.77B3.56B3.95B4.83B6.49B
Gross Profit1.93B2.22B2.53B3.02B4.18B
Gross Margin41.1%38.4%39.1%38.5%39.2%
Research & Development00000
Selling, General & Admin126.73M150.39M179.09M235.49M1.75B
Operating Expenses1.17B1.47B1.59B1.88B3.82B
Depreciation & Amortization1.05B1.34B1.44B1.68B2.14B
EBITDA1.71B2.04B2.4B2.78B2.31B
EBITDA Margin36.4%35.3%37.1%35.4%21.7%
Operating Income763.36M746.22M940.45M1.15B355.17M
Operating Margin16.2%12.9%14.5%14.6%3.3%
Interest Income00000
Interest Expense489.85M529.52M607.85M574.26M651.96M
Other Income / Expenses(380.16M)(578.41M)(575.95M)(170.14M)599.55M
Income Before Tax383.19M167.82M364.5M975.56M954.72M
Pre-Tax Margin8.1%2.9%5.6%12.4%9.0%
Income Tax Expense8.71M7.25M6.36M2.7M(7.12M)
Net Income336.14M141.21M340.09M951.68M936.85M
Net Margin7.1%2.4%5.2%12.1%8.8%
EPS (Basic)0.790.310.661.581.41
EPS (Diluted)0.780.300.661.571.39
Weighted Avg Shares424.98M462.19M515.63M602.98M665.64M
Weighted Avg Shares (Diluted)426.84M465.16M518.7M608.75M679.52M

Welltower Inc.

NYSE:WELL

Intrinsic Alpha fair value

Locked

Current Price

$247.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.